Effective synthesis of 3'-deoxy-3'-azido nucleosides for antiviral and antisense ribonucleic guanidine (RNG) applications

Nucleosides, Nucleotides and Nucleic Acids

Volumn 32, Issue 3, 2013, Pages 109-123

  Samuels, Eric R ^a   McNary, Joshua ^a   Aguilar, Maribel ^a   Awad, Ahmed M ^a  

^a CALIFORNIA STATE UNIVERSITY CHANNEL ISLANDS   (United States)

Author keywords

Antisense; Nucleoside 3' azido; Ribonucleic guanidine; RNA; Solid phase synthesis

Indexed keywords

3' DEOXY 3' AZIDO NUCELOSIDE; ANTIVIRUS AGENT; GUANIDINE; NUCLEOSIDE ANALOG; UNCLASSIFIED DRUG;

ARTICLE; CARBON NUCLEAR MAGNETIC RESONANCE; DRUG STRUCTURE; DRUG SYNTHESIS; PROTON NUCLEAR MAGNETIC RESONANCE;

AZIDES; DEOXYCYTIDINE; DEOXYURIDINE; NUCLEIC ACID CONFORMATION; OLIGODEOXYRIBONUCLEOTIDES; RNA, ANTISENSE;

EID: 84875942415     PISSN: 15257770     EISSN: 15322335     Source Type: Journal    
DOI: 10.1080/15257770.2013.766752     Document Type: Article

References (27)

1. Galmarini, C.M.; Mackey, J.R.; Dumontet, C. Nucleoside analogues and nucleobases in cancer treatment. Lancet Oncol. 2002, 3(7), 415-424.
2. De Clercq, E. Antiretroviral drugs. Curr. Opin. Pharmacol. 2010, 10(5), 507-515.
3. Uhlmann, E.; Peyman, A. Antisense oligonucleotides: a new therapeutic principle. Chem. Rev. 1990, 90(4), 543-584.
4. Opalinska, J.B.; Gewirtz, A.M. Nucleic-acid therapeutics: basic principles and recent applications. Nat. Rev. Drug Discov. 2002, 1, 503-514.
5. Cohen, J.S. Selective anti-gene therapy for cancer: principles and prospects. Tohoku J. Exp Med. 1992, 168(2), 351-359.
6. Pellestor, F.; Paulasova, P. The peptide nucleic acids (PNAs), powerful tools for molecular genetics and cytogenetics. Eur. J. Hum. Genet. 2004, 12(9), 694-700.
7. Stein, C.A.; Cohen, J.S. Oligonucleotides as inhibitors of gene expression: a review. Cancer Res. 1988, 48, 2659-2668.
8. Stein, C.A.; Cheng, Y.C. Antisense oligonucleotides as therapeutic agents - is the bullet really magical? Science. 1993, 261(5124), 1004-1012.
9. Barawkar, D.A.; Bruice, T.C. Synthesis, biophysical properties, and nuclease resistance properties of mixed backbone oligodeoxynucleotides containing cationic internucleoside guanidinium linkages: deoxynucleic guanidine/DNA chimeras. Proc. Natl. Acad. Sci. USA. 1998, 95(19), 11047-11052.
10. Dempcy, R.O.; Almarsson, O.; Bruice, T.C. Design and synthesis of deoxynucleic guanidine: a polycation analogue of DNA. Proc. Natl. Acad. Sci. USA. 1994, 91(17), 7864-7868.
11. Dempcy, R.O.; Browne, K.A.; Bruice, T.C. Synthesis of the polycation thymidyl DNG, its fidelity in binding polyanionic DNA/RNA, and the stability and nature of the hybrid complexes. J. Am. Chem. Soc. 1995, 117(22), 6140-6141.
12. Linkletter, B.A.; Szabo, I.E.; Bruice, T.C. Solid-phase synthesis of oligopurine deoxynucleic guanidine (DNG) and analysis of binding with DNA oligomers. Nucleic Acids Res. 2001, 29(11), 2370-2376.
13. Dempcy, R.O.; Browne, K.A.; Bruice, T.C. Synthesis of a thymidyl pentamer of deoxyribonucleic guanidine and binding studies with DNA homopolynucleotides. Proc. Natl. Acad. Sci. USA. 1995, 92(13), 6097-6101.
14. Dempcy, R.O.; Luo, J.; Bruice, T.C. Design and synthesis of ribonucleic guanidine: a polycationic analog of RNA. Proc. Natl. Acad. Sci. USA. 1996, 93(9), 4326-4330.
15. Kojima, N.; Szabo, I.E.; Bruice, T.C. Synthesis of ribonucleic guanidine: replacement of the negative phosphodiester linkages of RNA with positive guanidinium linkages. Tetrahedron. 2002, 58(2), 867-879.
16. Awad, A.M.; Collazo, M.J.; Carpio, K.; Flores, C.; Bruice, T.C. A convenient synthesis of the cytidyl 3-terminal monomer for solid-phase synthesis of RNG oligonucleotides. Tetrahedron Lett. 2012, 53, 3792-3794.
17. Gryaznov, S.M. Oligonucleotide N3→P5 phosphoramidates and thio-phoshoramidates as potential therapeutic agents. Chem. Biodivers. 2010, 7, 477-493.
18. Herdewijn, P. Anchimeric assistance of a 5-O-carbonyl function for inversion of configuration at the 3-carbon atom of 2-deoxyadenosine. Synthesis of 3-azido-2,3-dideoxyadenosine and 3-azido-2,3- dideoxyinosine. J. Org. Chem. 1988, 53, 5050-5053.
19. Szabo, I.E.; Bruice, T.C. DNG cytidine: synthesis and binding properties of octameric guanidiniumlinked deoxycytidine oligomer. Bioorg. Med. Chem. 2004, 12(15), 4233-4244.
20. Ogilvie, K.K.; Beaucage, S.L.; Schifman, A.L.; Theriault, N.Y.; Sadana, K.L. The synthesis of oligoribonucleotides. II. The use of silyl protecting groups in nucleoside and nucleotide chemistry. VII. Can. J. Chem. 1978, 56(21), 2768-2780.
21. Crouch, R.D. Selective monodeprotection of bis-silyl ethers. Tetrahedron. 2004, 60, 5833-5871.
22. Gait, M.J. in Oligonucleotide Synthesis: A Practical Approach, IRL: Oxford Oxfordshire, Washington, DC, 1984.
23. Zhu, X.; Williams, H.J.; Scott, A.I. An improved transient method for the synthesis of N-benzoylated nucleosides. Synth. Commun. 2003, 33, 1233-1243.
24. Pedersen, D.S.; Rosenbohm, C. Dry column vacuum chromatography. Synthesis. 2001, 16, 2431-2434.
25. Pierra, C.; Amador, A.; Badaroux, E.; Storer, R.; Gosselin, G. Synthesis of 2'-C-methylcytidine and 2'-C-methyluridine derivatives modified in the 3'-position as potential antiviral agents. Coll. Czech. C. C. 2006, 71, 991-1010.
26. Aljarah, M.; Couturier, S.; Mathe, C.; Perigaud, C. Synthesis of 3'-deoxy-3'-C-methyl nucleoside derivatives. Bioorg. Med. Chem. 2008, 16, 7436-7442.
27. Mentel, R.; Kinder, M.; Wegner, U.; von Janta-Lipinski, M.; Matthes, E. Inhibitory activity of 3'-fluoro-2' deoxythymidine and related nucleoside analogues against adenoviruses in vitro. Antiviral Res. 1997, 34, 113-119.